MELPHALAN THERAPY OF POLYCYTHEMIA VERA

[1] HEMORRHAGIC THROMBOCYTHEMIA - CONTROL OF POSTSPLENECTOMY THROMBOCYTOSIS WITH MELPHALAN [J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1970, 36 (01): : 61 - +

[2] ATTEMPTS AT CHEMOTHERAPY OF MALIGNANT DISEASES [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1955, 7 (05) : 297 - 313

[3] CLINICAL EXPERIENCES WITH SARCOLYSIN IN NEOPLASTIC DISEASES [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) : 1128 - 1132

[4] CHIEVITZ E, 1962, ACTA MED SCAND, V172, P513

[5] PHYSIOPATHOLOGY AND COURSE OF POLYCYTHEMIA VERA AS RELATED TO THERAPY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1950, 142 (11): : 790 - 797

[6] DAMESHEK W, 1964, LEUKEMIA

[7] ELLISON RR, 1953, CANCER-AM CANCER SOC, V6, P327, DOI 10.1002/1097-0142(195303)6:2<327::AID-CNCR2820060216>3.0.CO

[8] 2-W

[9] HEMATOLOGICAL EFFECTS OF THE ALKYLATING AGENTS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) : 826 - 833

[10] FEINGOLD M, 1960, ARCH INTERN MED, V124, P66

[1] HEMORRHAGIC THROMBOCYTHEMIA - CONTROL OF POSTSPLENECTOMY THROMBOCYTOSIS WITH MELPHALAN [J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1970, 36 (01): : 61 - +

[2] ATTEMPTS AT CHEMOTHERAPY OF MALIGNANT DISEASES [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1955, 7 (05) : 297 - 313

[3] CLINICAL EXPERIENCES WITH SARCOLYSIN IN NEOPLASTIC DISEASES [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) : 1128 - 1132

[4] CHIEVITZ E, 1962, ACTA MED SCAND, V172, P513

[5] PHYSIOPATHOLOGY AND COURSE OF POLYCYTHEMIA VERA AS RELATED TO THERAPY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1950, 142 (11): : 790 - 797

[6] DAMESHEK W, 1964, LEUKEMIA

[7] ELLISON RR, 1953, CANCER-AM CANCER SOC, V6, P327, DOI 10.1002/1097-0142(195303)6:2<327::AID-CNCR2820060216>3.0.CO

[8] 2-W

[9] HEMATOLOGICAL EFFECTS OF THE ALKYLATING AGENTS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) : 826 - 833

[10] FEINGOLD M, 1960, ARCH INTERN MED, V124, P66